Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database

Qingran Yan, Cosimo Bruni, Alexandru Garaiman, Carina Mihai, Suzana Jordan, Mike Oliver Becker, Muriel Elhaï, Rucsandra Dobrota, P. Liubov, J. Henes, É. Hachulla, Elise Siegert, Alexandra Balbir‐Gurman, Giovanna Cuomo, Gabriela Riemekasten, Stefan Heitmann, D. M. Reza Beigi, Susanne Ullman, Petros P. Sfikakis, Francesca Ingegnoli, Vera Bernardino, Marie‐Elise Truchetet, Madelon C Vonk, Francesco Del Galdo, Anna‐Maria Hoffmann‐Vold, Shuang Ye, Oliver Distler